Page last updated: 2024-10-29

iohexol and Osteosarcoma

iohexol has been researched along with Osteosarcoma in 1 studies

Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.

Osteosarcoma: A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sun, TT1
Tao, XF1
Shi, HM1

Other Studies

1 other study available for iohexol and Osteosarcoma

ArticleYear
Spontaneous osteosarcoma in craniomaxillofacial fibrous dysplasia: clinical and computed tomographic features in 8 cases.
    Oral surgery, oral medicine, oral pathology and oral radiology, 2014, Volume: 118, Issue:1

    Topics: Adolescent; Adult; Child; Contrast Media; Female; Fibrous Dysplasia of Bone; Humans; Iohexol; Male;

2014